 intens therapi small-cel lung cancer carboplatin cisplatin ifosfamid mid-cycl vincristin radiotherapi patient small-cel lung cancer patient limited-stag LS diseas patient extensive-stag ES diseas good perform statu intens therapi carboplatin cisplatin ifosfamid vincristin day carboplatin cycl maximum cycl weekli interv cisplatin combin carboplatin combin prophylact cranial irradi first cycl chemotherapi thorac irradi third cycl median nadir neutrophil /L platelet /L chemotherapi dosag respons myelosuppress treatment blood count recoveri sixty-eight percent patient cycl chemotherapi death treatment-rel neutropenia twenty-eight patient complet respons CR assess month end treatment patient partial respons PR median durat CR month PR month cerebr metastas patient appar sole site relaps CR patient median surviv total group month actual surviv minimum follow-up month